tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IDYA Stock Latest News

IDEAYA Biosciences’ Trial Expansion and Regulatory Uncertainties Lead to Hold Rating
RatingsIDEAYA Biosciences’ Trial Expansion and Regulatory Uncertainties Lead to Hold Rating
3d ago
IDYA
IDEAYA Biosciences: Promising Prospects with Strategic Phase 3 Trial and Key Data Catalysts
PremiumRatings
IDEAYA Biosciences: Promising Prospects with Strategic Phase 3 Trial and Key Data Catalysts
4d ago
IDYA
IDEAYA Biosciences: Promising Outlook with Regulatory Alignment and Strategic Expansion in Clinical Trials
PremiumRatings
IDEAYA Biosciences: Promising Outlook with Regulatory Alignment and Strategic Expansion in Clinical Trials
5d ago
IDYA
Ideaya trial design consisent with guidance, says Oppenheimer
PremiumThe Fly
Ideaya trial design consisent with guidance, says Oppenheimer
5d ago
IDYA
Morning Movers: Goldman Sachs gains following first quarter results
PremiumThe Fly
Morning Movers: Goldman Sachs gains following first quarter results
5d ago
GS
BKD
Ideaya Biosciences announces FDA Type D meeting for darovasertib trial design
PremiumThe FlyIdeaya Biosciences announces FDA Type D meeting for darovasertib trial design
5d ago
IDYA
Ideaya Biosciences initiates expansion in IDE397 trial
Premium
The Fly
Ideaya Biosciences initiates expansion in IDE397 trial
9d ago
GILD
IDYA
IDEAYA Biosciences Announces Board Restructuring Plans
Premium
Company Announcements
IDEAYA Biosciences Announces Board Restructuring Plans
17d ago
8K
IDYA
IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments
PremiumRatings
IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments
19d ago
IDYA
Ideaya Biosciences granted breakthrough therapy designation for darovasertib
PremiumThe Fly
Ideaya Biosciences granted breakthrough therapy designation for darovasertib
19d ago
IDYA
Ideaya Biosciences announces research collaboration with Attmos
PremiumThe Fly
Ideaya Biosciences announces research collaboration with Attmos
2M ago
IDYA
Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures
PremiumRatings
Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures
2M ago
IDYA
IDEAYA Biosciences Reports 2024 Financials and Business Update
PremiumCompany AnnouncementsIDEAYA Biosciences Reports 2024 Financials and Business Update
2M ago
IDYA
IDEAYA Biosciences: Strategic Advancements and Promising Clinical Developments Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Strategic Advancements and Promising Clinical Developments Support Buy Rating
2M ago
IDYA
Strategic Advancements and Clinical Progress Drive IDEAYA Biosciences’ Buy Rating
Premium
Ratings
Strategic Advancements and Clinical Progress Drive IDEAYA Biosciences’ Buy Rating
2M ago
IDYA
Ideaya Biosciences price target lowered to $40 from $53 at Oppenheimer
PremiumThe Fly
Ideaya Biosciences price target lowered to $40 from $53 at Oppenheimer
2M ago
AMGN
IDYA
Ideaya Biosciences enters additional supply pact with Gilead for IDE397
PremiumThe Fly
Ideaya Biosciences enters additional supply pact with Gilead for IDE397
2M ago
GILD
IDYA
Ideaya Biosciences reports Q4 EPS ($1.49), consensus (62c)
PremiumThe Fly
Ideaya Biosciences reports Q4 EPS ($1.49), consensus (62c)
2M ago
IDYA
IDEAYA Biosciences Appoints New Chief Financial Officer
PremiumCompany Announcements
IDEAYA Biosciences Appoints New Chief Financial Officer
2M ago
8K
IDYA
Ideaya enters license agreement for SHR-4849 with Jiangsu Hengrui
PremiumThe FlyIdeaya enters license agreement for SHR-4849 with Jiangsu Hengrui
4M ago
IDYA
IDEAYA Biosciences (IDYA): A Down Year Presents a Window of Opportunity for Investors
Premium
Market News
IDEAYA Biosciences (IDYA): A Down Year Presents a Window of Opportunity for Investors
4M ago
GSK
IDYA
Ideaya announces IDMC recommendation for darovasertib, crizotinib combination
Premium
The Fly
Ideaya announces IDMC recommendation for darovasertib, crizotinib combination
4M ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >